AU6097100A - Crosslinked dna condensate compositions and gene delivery methods - Google Patents
Crosslinked dna condensate compositions and gene delivery methodsInfo
- Publication number
- AU6097100A AU6097100A AU60971/00A AU6097100A AU6097100A AU 6097100 A AU6097100 A AU 6097100A AU 60971/00 A AU60971/00 A AU 60971/00A AU 6097100 A AU6097100 A AU 6097100A AU 6097100 A AU6097100 A AU 6097100A
- Authority
- AU
- Australia
- Prior art keywords
- gene delivery
- delivery methods
- crosslinked dna
- dna condensate
- condensate compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001476 gene delivery Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14360099P | 1999-07-13 | 1999-07-13 | |
| US60143600 | 1999-07-13 | ||
| US15776199P | 1999-10-05 | 1999-10-05 | |
| US60157761 | 1999-10-05 | ||
| PCT/US2000/019164 WO2001004135A2 (en) | 1999-07-13 | 2000-07-13 | Crosslinked dna condensate compositions and gene delivery methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6097100A true AU6097100A (en) | 2001-01-30 |
Family
ID=26841217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU60971/00A Abandoned AU6097100A (en) | 1999-07-13 | 2000-07-13 | Crosslinked dna condensate compositions and gene delivery methods |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6097100A (en) |
| WO (1) | WO2001004135A2 (en) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2180416B1 (en) | 2001-03-12 | 2004-06-01 | BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. | PROCEDURE FOR THE PREPARATION OF STABILIZED REACTION MIXTURES, TOTAL OR PARTIALLY DESIRED, THAT INCLUDE, AT LEAST, ONE ENZYME, REACTION MIXES AND KITS CONTAINING THEM. |
| US7894999B2 (en) | 2001-03-27 | 2011-02-22 | Samuel Bogoch | Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds |
| US7774144B2 (en) | 2001-10-26 | 2010-08-10 | Samuel Bogoch | System and method for identifying complex patterns of amino acids |
| US7442761B2 (en) | 2003-06-06 | 2008-10-28 | Samuel Bogoch | Replikin peptides and uses thereof |
| US7420028B2 (en) | 2001-03-27 | 2008-09-02 | Samuel Bogoch | Replikins and methods of identifying replikin-containing sequences |
| US7189800B2 (en) | 2001-03-27 | 2007-03-13 | Samuel Bogoch | Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| US7452963B2 (en) | 2001-03-27 | 2008-11-18 | Samuel Bogoch | Replikin peptides and antibodies therefore |
| NZ592340A (en) | 2001-03-27 | 2012-12-21 | Elenore S Bogoch | A method for making a virus vaccine compising Replikin peptides |
| SG153654A1 (en) * | 2001-07-09 | 2009-07-29 | Samuel Bogoch | Replikin peptides and uses thereof |
| US8494781B2 (en) | 2003-06-06 | 2013-07-23 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
| US9254315B2 (en) | 2004-04-28 | 2016-02-09 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
| EA010374B1 (en) | 2004-07-16 | 2008-08-29 | Микромет Аг | Expression-enhanced polypeptides |
| JP2010507361A (en) | 2006-07-31 | 2010-03-11 | キュアバック ゲーエムベーハー | Specifically, a nucleic acid represented by the general formula (I): GlXmGn or the general formula (II): ClXmCn as an immunostimulant / adjuvant |
| EP2092059A4 (en) | 2006-10-24 | 2012-03-28 | Bogoch Samuel | A method of predicting influenza outbreaks |
| CN101969993B (en) | 2007-05-30 | 2013-10-16 | 塞缪尔·博戈奇 | Synthetic Replikin Peptides Against Pathogen Infection of Invertebrates in Aquaculture |
| WO2009030254A1 (en) | 2007-09-04 | 2009-03-12 | Curevac Gmbh | Complexes of rna and cationic peptides for transfection and for immunostimulation |
| MX2010008468A (en) | 2008-01-31 | 2010-08-30 | Curevac Gmbh | NUCLEIC ACIDS COMPRISING FORMULA (NuGlX<sub >mGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS. |
| WO2010037408A1 (en) | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| WO2010059829A2 (en) * | 2008-11-19 | 2010-05-27 | Mdrna, Inc. | Compositions and methods for triggered release rna therapeutics |
| US9233148B2 (en) | 2009-01-09 | 2016-01-12 | Samuel Bogoch | Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza |
| US20110053829A1 (en) | 2009-09-03 | 2011-03-03 | Curevac Gmbh | Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| WO2012013326A1 (en) * | 2010-07-30 | 2012-02-02 | Curevac Gmbh | Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation |
| AU2012283914A1 (en) | 2011-07-20 | 2014-01-30 | Bogoch, Elanore S. | Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| WO2013113326A1 (en) | 2012-01-31 | 2013-08-08 | Curevac Gmbh | Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen |
| KR20160044566A (en) | 2013-08-21 | 2016-04-25 | 큐어백 아게 | Respiratory syncytial virus (RSV) vaccine |
| CA2936286A1 (en) | 2014-04-01 | 2015-10-08 | Curevac Ag | Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant |
| US11680085B2 (en) | 2017-06-14 | 2023-06-20 | Virometix Ag | Cyclic peptides for protection against respiratory syncytial virus |
| US20220054619A1 (en) | 2018-12-20 | 2022-02-24 | Virometix Ag | Lipopeptide building blocks and synthetic virus-like particles |
| WO2022063990A1 (en) | 2020-09-28 | 2022-03-31 | Dbv Technologies | Particle comprising an rsv-f protein for use in rsv vaccination |
| WO2025012364A1 (en) | 2023-07-12 | 2025-01-16 | Virometix Ag | Compositions of pneumococcal antigens |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE258434T1 (en) * | 1993-07-14 | 2004-02-15 | Univ California | SELF-ASSEMBLY POLYNUCLEOTIDE DELIVERY SYSTEM CONTAINING DENDRIMER POLYCATIONS |
| WO1998019711A1 (en) * | 1996-11-04 | 1998-05-14 | Regents Of The University Of Michigan | Peptides for gene delivery |
| AU3758199A (en) * | 1998-04-23 | 1999-11-08 | Regents Of The University Of Michigan, The | Peptides for efficient gene transfer |
-
2000
- 2000-07-13 AU AU60971/00A patent/AU6097100A/en not_active Abandoned
- 2000-07-13 WO PCT/US2000/019164 patent/WO2001004135A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001004135A2 (en) | 2001-01-18 |
| WO2001004135A3 (en) | 2001-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6097100A (en) | Crosslinked dna condensate compositions and gene delivery methods | |
| AU9692198A (en) | Gene delivery compositions and methods | |
| AU2625501A (en) | Compositions and methods for gene silencing | |
| AU3369900A (en) | Gene silencing | |
| AU2002336367A1 (en) | Adamts13 genes and proteins and variants, and uses thereof | |
| AU2001245987A1 (en) | Compositions and methods for gene therapy | |
| AU3072500A (en) | Rhamnosyl-transferase gene and uses thereof | |
| AU2002365188A1 (en) | Nucleic acid delivery and expression | |
| AU2001238485A1 (en) | Methods and compositions for gene delivery | |
| AU5471600A (en) | Variant tlr4 nucleic acid and uses thereof | |
| AUPQ262599A0 (en) | Gene expression | |
| AU5245900A (en) | Novel protein and dna thereof | |
| AU2407600A (en) | Microsatellite dna markers and uses thereof | |
| AU5178999A (en) | Nucleic acid delivery | |
| AU6094200A (en) | Nor gene compositions and methods for use thereof | |
| AU2001270478A1 (en) | Gene expression in biological conditions | |
| AU2400401A (en) | Novel phosphodiesterases and genes thereof | |
| AU2153401A (en) | Gene expression in biological conditions | |
| AU1894601A (en) | Novel gene and use thereof | |
| AU2600100A (en) | Methods and compositions for delivering nucleic acids | |
| AU5617200A (en) | Nodavirus-based dna expression vector and uses thereof | |
| AU1873201A (en) | Interferon-alpha induced gene | |
| AU6773200A (en) | Egfh2 genes and gene products | |
| AU2001259169A1 (en) | Cesert genes, proteins, and modulatory compounds | |
| AU5474400A (en) | Compositions and methods for targeted gene insertion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |